V-APC 60-01

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2014-11-26 for V-APC 60-01 manufactured by Harvest Technologies, Corp..

Event Text Entries

[18541834] The customer reported that a patient (giant american thoroughbred) underwent intra-lesional platelet-rich plasma (prp) therapy for tendinopathy of the deep digital flexor tendon in the mid-metatarsal regional of the left hind. Two days later, the patient was found to be acutely lame on the left hind and the limb was swollen at the fetlock. An ultrasound on (b)(6) 2014 showed further tendon deterioration and tendon sheath effusion. His condition continued to decline despite laser treatments, cold therapy and leg wraps. The customer is alleging the event is a result of either a reaction to the v-apc 60-01 product or the patient experienced a severe infection related to the prp injection process. He was confined to stall rest and started on a 10 day course of trimethoprimsulfamethoxazole twice daily, as well as a 10 day course of iv gentamicin sulfate. Equine information: id - (b)(6), male, born in 1999, weight is not available. This report is being filed due to equine patient injury using a device platform that is similarly marketed within the us for human use.
Patient Sequence No: 1, Text Type: D, B5


[18815488] Per the vet report, the patient was confined to stall rest on (b)(6) 2014 and started on a 10 day course of trimethoprim-sulfamethoxazole twice daily, as well as a 10 day course of iv gentamicin sulfate. On (b)(6) 2014, additional radiograph and ultrasound showed significant deterioration of the left deep digital flexor tendon. Amikacin was injected into his left hind tendon sheath on (b)(6) 2014. Bacterial infection from the prp injection cannot be ruled out as a possible contributing factor. Infection could have been the result of introduction of bacteria from his skin and hair or from contaminated product. Prp injection can result in localized inflammation, and inflammation can lead to damage of the tendon, although the degree of reaction the patient exhibits is uncommon. On (b)(6) 2014, a recheck ultrasound was performed and the tendinitis had not worsened. By (b)(6) 2014, the patient was able to maintain a comfortable walk. The injury may take up to 12 months before it is healed. Investigation is in process. A follow up report will be provided.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1225520-2014-00002
MDR Report Key4364645
Report Source05
Date Received2014-11-26
Date of Report2014-11-24
Date of Event2014-10-28
Device Manufacturer Date2014-06-26
Date Added to Maude2014-12-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactJAMES BAUER
Manufacturer Street40 GRISSOM RD, SUITE 100
Manufacturer CityPLYMOUTH MA 02360
Manufacturer CountryUS
Manufacturer Postal02360
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameV-APC 60-01
Generic NamePRP PROCESSING KIT, EQUINE
Product CodeORG
Date Received2014-11-26
Model NumberV-APC 60
Catalog NumberV-APC 60
Lot NumberVA60-01-0032
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerHARVEST TECHNOLOGIES, CORP.
Manufacturer AddressPLYMOUTH MA US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2014-11-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.